Correlation Between Cipher Pharmaceuticals and Decibel Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Decibel Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Decibel Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Decibel Cannabis, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Decibel Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Decibel Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Decibel Cannabis.

Diversification Opportunities for Cipher Pharmaceuticals and Decibel Cannabis

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cipher and Decibel is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Decibel Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Cannabis and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Decibel Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Cannabis has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Decibel Cannabis go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Decibel Cannabis

Assuming the 90 days trading horizon Cipher Pharmaceuticals is expected to under-perform the Decibel Cannabis. But the stock apears to be less risky and, when comparing its historical volatility, Cipher Pharmaceuticals is 3.05 times less risky than Decibel Cannabis. The stock trades about -0.06 of its potential returns per unit of risk. The Decibel Cannabis is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  6.50  in Decibel Cannabis on September 18, 2024 and sell it today you would earn a total of  0.50  from holding Decibel Cannabis or generate 7.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Decibel Cannabis

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Decibel Cannabis 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Decibel Cannabis showed solid returns over the last few months and may actually be approaching a breakup point.

Cipher Pharmaceuticals and Decibel Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Decibel Cannabis

The main advantage of trading using opposite Cipher Pharmaceuticals and Decibel Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Decibel Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Cannabis will offset losses from the drop in Decibel Cannabis' long position.
The idea behind Cipher Pharmaceuticals and Decibel Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA